Home Administration of NivestimTM in the Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia
Clinical trial NCT02956967 · COMPLETED
Trial details
- NCT number
- NCT02956967
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-09-23
- Primary completion
- 2016-12-12
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.